Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950170-25-036537
Filing Date
2025-03-10
Accepted
2025-03-10 17:29:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 11628
  Complete submission text file 0000950170-25-036537.txt   13345
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Subject) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-85653 | Film No.: 25725023
SIC: 7389 Services-Business Services, NEC
(CF Office: 07 Trade & Services)

Mailing Address 2001 SHAWNEE MISSION PARKWAY SHAWNEE MISSION KS 66205
Business Address 2001 SHAWNEE MISSION PARKWAY SHAWNEE MISSION KS 66205 913-951-2700
Whetstone Capital Advisors, LLC (Filed by) CIK: 0001607278 (see all company filings)

EIN.: 273522666 | State of Incorp.: KS | Fiscal Year End: 1213
Type: SCHEDULE 13D/A